Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zona Health has commercialized the "Zona Plus," a handheld biofeedback device that uses personalized isometric handgrip exercise to lower blood pressure. Clinical studies and meta-analysis have shown significant reductions in systolic and diastolic blood pressure with regular use. The product leverages over 40 years of research in cardiovascular physiology and has been available commercially for several years in North America. The company reports $500K in trailing twelve months revenue as of the latest data available. FDA registration lists the device under powered exercise equipment; however, its intended use for hypertension management distinguishes it from generic fitness devices. No clinical pipeline beyond this flagship product was identified. Users are guided through a daily protocol via software-driven feedback; results can be tracked electronically or uploaded to an online portal for monitoring progress.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zona Health.